drugset / Trial / NCT06869252

Autologous Adipose Cells Therapy

NCT06869252 ↗

Phase 1/2 Recruiting 40 enrolled CERM INC.
NaSingle-groupOpen-labelTreatment

Summary

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Timeline

Start
2025-08-01
Primary completion
2025-11-01
Completion
2026-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Adipose Cells Therapy Cell therapy — —